Updated

Private equity firm Blackstone is reportedly exploring a sale of ZO Skin Health, the skincare company it backs, in a deal that could value the business at around $2 billion. The potential exit would mark another realization for Blackstone's consumer-focused portfolio. The move comes amid continued private equity activity in the consumer and beauty sectors, as firms look to monetize holdings acquired in prior investment cycles.